Gene expression profiling and analysis of human pancreatic adenocarcinomas by cDNA microarrays, quantitative real-time RT-PCR and immunohistochemistry demonstrated increased expression of NGAL in malignant pancreatic tissue compared to normal [38]. Here, LCN2 is linked to pancreatic adenocarcinoma.